A buyback announcement like “₹1,000 per share” can quickly catch attention, especially when the stock is trading lower in the market. For many investors, the first instinct is simple: buy now, tender later, and capture the difference. But with the Windlas Biotech buyback 2026, the real question is not just about the premium. It is […]
For many people, starting is the hardest part of investing. A common thought is: is ₹10,000 enough to begin? Some hesitate because the amount feels small compared to what others may be investing. Others are unsure how such an amount actually works once invested. At the same time, financial platforms often show charts, returns, and […]
Many investors feel a mix of curiosity and caution when evaluating SME IPOs. The growth stories can look attractive, yet smaller businesses often carry risks that are not immediately visible in headline numbers. The Shreedhar Spinners IPO arrives at a time when investors are actively searching for manufacturing businesses with operating track records and expansion […]
inXits is India’s SEBI-registered Investment Advisor, Research Analyst and AMFI registered Mutual Fund Distributor. Manage all your investments, bank accounts and loans in one-place with certified professional backed guidance — 24/7 free support.
SEBI Registered5,000+ FamiliesISO 27001 CertifiedFree to Start